Evaluation of antimicrobial susceptibilities of rapidly growing mycobacteria by Sensititre RAPMYCO panel

New Microbiologica

Volumn 35, Issue 1, 2012, Pages 73-76

  Cavusoglu, Cengiz ^a   Gurpinar, Tugba ^b   Ecemis, Talat ^b  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b CELAL BAYAR UNIVERSITY   (Turkey)

Author keywords

Antimicrobial susceptibility; Broth microdilution; Rapidly growing mycobacteria; Sensititre RAPMYCO

Indexed keywords

ANTIINFECTIVE AGENT;

ARTICLE; DRUG EFFECT; GENETICS; HUMAN; ISOLATION AND PURIFICATION; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; MYCOBACTERIOSIS; MYCOBACTERIUM;

ANTI-BACTERIAL AGENTS; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM; MYCOBACTERIUM INFECTIONS;

CORYNEBACTERINEAE; MYCOBACTERIUM ABSCESSUS; MYCOBACTERIUM CHELONAE; MYCOBACTERIUM FORTUITUM; MYCOBACTERIUM PEREGRINUM;

EID: 84856916620     PISSN: 11217138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. BICMEN C., COSKUN M., GUNDUZ A.T., SENOL G., CIRAK A.K., TIBET G. (2010). Nontuberculous mycobacteria isolated from pulmonary specimens between 2004 and 2009: causative agent or not? New Microbiol. 33, 399-403.
2. BROWN B.A., WALLACE R.J. JR., ONY1 G.O., DE ROSAS V., WALLACE R.J. 3RD. (1992). Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae, and M. chelonae-like organisms. Antimicrob. Agents. Chemother. 36, 180-184.
3. BROWN-ELL1OTT B.A., WALLACE R.J. JR. (2002a). Clinical and taxonomic status of pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteria. Clin. Microbiol. Rev. 15, 716-746. (Pubitemid 41199631)
4. BROWN-ELLiOTT B.A., WALLACE R.J. JR., CRiST C.J., MANN L., WiLSON R.W. (2002b). Comparison of in vitro activities of gatifloxacin and ciprofloxacin against four taxa of rapidly growing mycobacteria. Antimicrob. Agents. Chemother. 46, 3283-3285.
5. CLiNiCAL AND LABORATORY STANDARDS INSTiTUTE. (2003). Susceptibility testing of mycobacteria, nocardia, and other aerobic actinomycetes; approved Standard. CLSI document M24-A. National Committee for Clinical Laboratory Standards, Wayne, Pa.
6. FERNÁNDEZ-ROBLAS R., ESTEBAN J., CABR1A F., LÓPEZ J.C., JiMÉNEZ M.S., SORiANO F. (2000). In vitro susceptibilities of rapidly growing mycobacteria to telithromycin (HMR 3647) and seven other antimicrobials. Antimicrob. Agents. Chemother. 44, 181-182. (Pubitemid 30010693)
7. FERNÁNDEZ-ROBLAS R., MART1N-DE-H1JAS N.Z., FERNÁNDEZ- MARTiNEZ A.I., GARCiA-ALMEIDiA D., GADEA I., ESTEBAN J. (2008). In vitro activities of tigecycline and 10 other antimicrobials against nonpigmented rapidly growing mycobacteria. Antimicrob. Agents. Chemother. 52, 4184-4186.
8. GAYATHR1 R., THERESE K.L., DEEPA P., MANGAi S., MADHAVAN H.N. (2010). Antibiotic susceptibility pattern of rapidly growing mycobacteria. J. Postgrad. Med. 56, 76-78.
9. SHEN G.H., WU B.D., WU K.M., CHEN J.H. (2007). In Vitro activities of isepamicin, other aminoglycosides, and capreomycin against clinical isolates of rapidly growing mycobacteria in Taiwan. Antimicrob. Agents. Chemother. 51, 1849-1851.
10. SWENSON J.M., WALLACE R.J. JR., SiLCOX V.A., THORNSBERRY C. (1985). Antimicrobial susceptibility of five subgroups of Mycobacterium fortuitum and Mycobacterium chelonae. Antimicrob. Agents. Chemother. 28, 807-811. (Pubitemid 16196919)
11. VERA-CABRERA L., BROWN-ELL1OTT B.A., WALLACE R.J. JR., OCAMPO-CANDiANi J., WELSH O., CHOi S.H., ET AL. (2006). In vitro activities of the novel oxazolidinones DA- 7867 and DA-7157 against rapidly and slowly growing mycobacteria. Antimicrob. Agents. Chemother. 50, 4027-4029. (Pubitemid 44865145)
12. WALLACE R.J. JR., BEDSOLE G., SUMTER G., SANDERS C.V., STEELE L.C., BROWN B.A., ET AL. (1990). Activities of ciprofloxacin and ofloxacin against rapidly growing mycobacteria with demonstration of acquired resistance following single-drug therapy. Antimicrob. Agents. Chemother. 34, 65-70. (Pubitemid 20019965)
13. WALLACE R.J. JR., BROWN B.A., ONYI G.O. (1991). Susceptibilities of Mycobacterium fortuitum biovar. fortuitum and the two subgroups of Mycobacterium chelonae to imipenem, cefmetazole, cefoxitin, and amoxicillin-clavulanic acid. Antimicrob. Agents. Chemother. 35, 773-775.
14. WALLACE R.J. JR., BROWN-ELL1OTT B.A., WARD S.C., CRiST C.J., MANN L.B., WiLSON R.W. (2001). Activities of linezolid against rapidly growing mycobacteria. Antimicrob. Agents. Chemother. 45, 764- 767. (Pubitemid 32182022)
15. WALLACE R.J. JR., BROWN-ELL1OTT B.A., CRiST C.J., MANN L., WiLSON R.W. (2002). Comparison of the in vitro activity of the glycylcycline tigecycline (formerly GAR-936) with those of tetracycline, minocycline, and doxycycline against isolates of nontuberculous mycobacteria. Antimicrob. Agents. Chemother. 46, 3164-3167.